Institutional members access full text with Ovid®

Share this article on:

Denosumab (Prolia): A new option in the treatment of osteoporosis

Belavic, Jennifer M. PharmD

doi: 10.1097/01.NPR.0000391178.47878.73
Department: Drug News

Jennifer M. Belavic is a clinical pharmacist in the trauma intensive care unit at University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, Pa.

© 2011 Lippincott Williams & Wilkins, Inc.